Optune transducers
Ended Awarded Last action
- Contract number
- 36C26326N0413
- Awardee
-
Novocure Inc. UEI P3S3GK3DTUA8
- Awarding agency
-
Veterans Integrated Service Network 23
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $49,749
Award facts
- Contract value 100% obligated
- $49,748.73 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 334510 Electromedical and Electrotherapeutic Apparatus Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Minneapolis, MN 55417, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Veterans Affairs, Veterans Integrated Service Network 23, awarded a $49,748.73 firm fixed-price delivery order to Novocure Inc. for Optune transducers on March 12, 2026, with an ultimate completion date of June 10, 2026. The delivery order, which carries no set-aside designation, will be performed in Minneapolis, Minnesota. Novocure Inc., a foreign-owned medical device manufacturer, specializes in Tumor Treating Fields (TTFields) technology for solid tumor cancer treatment, including FDA-approved applications for glioblastoma and mesothelioma. This delivery order is issued under Novocure's General Services Administration Federal Supply Schedule contract (FSS-65-II-A) for Medical Equipment and Supplies, valued at $28.85 million and extending through October 31, 2027.
This delivery order represents a continuation of the VA's strategic initiative to expand veterans' access to innovative, non-invasive cancer treatment technologies across its medical facility network. Novocure serves as the sole source provider of Optune devices and associated transducer components to the Veterans Health Administration, with over 100 delivery orders and purchase orders issued under the FSS vehicle across multiple VISNs nationwide. As the prime contractor, Novocure maintains direct control and quality assurance over its proprietary technology with no subcontractor involvement. All contract awards to Novocure maintain firm fixed-price pricing structures without set-aside designations, reflecting the specialized and proprietary nature of the company's cancer treatment systems.
Quick answers
Who was awarded contract 36C26326N0413?
36C26326N0413 was awarded to Novocure Inc. by Veterans Integrated Service Network 23 (Veterans Health Administration) on March 12, 2026.
How much is contract 36C26326N0413 worth?
The government has obligated $49,749 on 36C26326N0413.
Is contract 36C26326N0413 an order under another contract?
Yes. 36C26326N0413 is a delivery order under 36F79723D0016, a federal supply schedule, on Medical Equipment and Supplies (FSS-65-II-A).
Was contract 36C26326N0413 competed?
The extent of competition for 36C26326N0413 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award